George W. Sledge Jr.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| 4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer (NCT03364348) | George W. Sledge Jr. | 2017-10-30 |
Track George W. Sledge Jr. automatically
Every clearance here is in the API, with alerts when new ones post.